relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

SB 650 allows New Hampshire alternative treatment centers to use CBD and other nonintoxicating hemp-derived cannabinoids (like CBD) in therapeutic products, while requiring these products to undergo contaminant and cannabinoid testing. It specifically prohibits centers from using any hemp-derived products containing natural THC over 0.3% (including delta-8, delta-9, or synthetic THC variants). The bill directly affects licensed alternative treatment centers by expanding permitted ingredients for therapeutic products under strict safety testing rules. It does not change recreational cannabis laws or allow intoxicating THC products. The law takes effect 60 days after passage.